Our company has passed the quality assurance system inspection conducted by the Drug Administration.

Release date:

2017-11-27

Author:

Quality Assurance Department, Wang Xiaoli

Source:


Abstract

Recently, inspection teams from the Beijing Municipal Administration for Market Regulation and the Daxing District Administration for Market Regulation visited our company to conduct routine follow-up inspections. The company’s General Manager, Zheng Haifa, Executive Deputy General Manager, Liu Jiankai, Quality Director, Li Xiangqun, and other relevant personnel accompanied the team throughout the process. Using methods such as interviews, on-site visits, document reviews, and record examinations, the inspection team conducted a comprehensive assessment of the operation of the company’s quality assurance system.

  Recently, inspection teams from the Beijing Municipal Administration for Market Regulation and the Daxing District Administration for Market Regulation conducted a routine follow-up inspection at our company. The company’s General Manager, Zheng Haifa, Executive Deputy General Manager, Liu Jiankai, Quality Director, Li Xiangqun, and other relevant personnel accompanied the inspectors throughout the process.

  The inspection team’s experts conducted a comprehensive review of the company’s quality assurance system by means of interviews, on-site visits, document reviews, and record examinations. In their final assessment, the experts concluded that the company’s quality assurance system is in compliance with the requirements of the relevant standards, expressing particular appreciation for the system’s thoroughness and practicality. They also provided specific recommendations and improvement measures to address the issues identified during the audit.

  Quality is a timeless priority, and supervisory audits have no end—only a beginning. Beijing Minhai Biotechnology Co., Ltd. will continuously optimize its workflows, pursue ongoing improvements, rigorously control every stage of quality, ensure that each product meets both customer expectations and legal and regulatory requirements, and remain committed to safeguarding human health.

 

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09